VXRT - Why Shares of Vaxart Jumped 31.2% in the First Half of 2021
Shares of Vaxart (NASDAQ: VXRT) jumped 31.2% through the first half of 2021, according to data from S&P Global Market Intelligence . That price at the end of July doesn't even begin to tell the story of those six months. Over the period, the stock rose as much as 300% and fell as low as 11% below where it began the year. The wild ride was thanks to two instances of the market anticipating clinical data and the painful realization that the company's vaccine pill isn't producing the immune response Wall Street wants to see.
For further details see:
Why Shares of Vaxart Jumped 31.2% in the First Half of 2021